ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 78 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 13.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $128,000 | -47.5% | 55,626 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $244,000 | -59.2% | 55,626 | -32.5% | 0.00% | -75.0% |
| Q1 2021 | $598,000 | +147.1% | 82,366 | +47.1% | 0.00% | +100.0% |
| Q4 2020 | $242,000 | +184.7% | 55,975 | +169.4% | 0.00% | +100.0% |
| Q3 2020 | $85,000 | -34.6% | 20,775 | -4.2% | 0.00% | 0.0% |
| Q2 2020 | $130,000 | +1.6% | 21,681 | +27.6% | 0.00% | -50.0% |
| Q1 2020 | $128,000 | -31.6% | 16,996 | +24.5% | 0.00% | 0.0% |
| Q4 2019 | $187,000 | – | 13,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
| RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
| Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
| Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
| Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
| Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
| Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |